Bonnie Ky, MD, MSCE, FACC
PHILADELPHIA – Bonnie Ky, MD, MSCE, FACC, an associate professor of Medicine and Epidemiology in the Perelman School of Medicine at the University of Pennsylvania, has been appointed Editor in Chief of the American College of Cardiology’s newest journal – JACC: CardioOncology. The journal will launch in September, and Ky will begin her five-year term in March 2019.
Ky, the founding director of the Penn Cardio-Oncology Center for Excellence, leads research efforts to better understand the cardiotoxic effects of various cancer therapies, focusing on the detection, prevention and treatment of heart disease in cancer patients. In her research, Ky studies advanced imaging, biomarker tools, and deep phenotyping techniques to identify cancer patients who are at increased risk for cardiotoxicity, and to develop strategies to prevent injury while delivering necessary cancer treatments.
As a part of her work, Ky leads a National Institutes of Health (NIH)-funded translational research program in cardio-oncology and is the Principal Investigator of multiple research studies focused on cardiotoxicity. She is also Chair of the Cardiotoxicity Subcommittee for the ECOG-ACRIN Cancer Research Group, which is funded by the National Cancer Institute, and director of the Penn Center for Quantitative Echocardiography.
The journal – which expands the family of JACC journals to eight, including the flagship JACC – will publish original research articles and state-of-the-art reviews related to the leading basic, translational and clinical investigations in cardio-oncology.
Ky received her undergraduate degree from Massachusetts Institute of Technology (M.I.T.) and medical degree from the Perelman School of Medicine at the University of Pennsylvania.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.